PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

'Nanosponge vaccine' fights MRSA toxins

2013-12-02
(Press-News.org) Contact information: Daniel Kane
dbkane@ucsd.edu
858-534-3262
University of California - San Diego
'Nanosponge vaccine' fights MRSA toxins

Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA—both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.

The nanosponges at the foundation of the experimental "toxoid vaccine" platform are bio-compatible particles made of a polymer core wrapped in a red-blood-cell membrane. Each nanosponge's red-blood-cell membrane seizes and detains the Staphylococcus aureus (staph) toxin alpha-haemolysin without compromising the toxin's structural integrity through heating or chemical processing. These toxin-studded nanosponges served as vaccines capable of triggering neutralizing antibodies and fighting off otherwise lethal doses of the toxin in mice.

Toxoid vaccines protect against a toxin or set of toxins, rather than the organism that produces the toxin(s). As the problem of antibiotic resistance worsens, toxoid vaccines offer a promising approach to fight infections without reliance on antibiotics.

"With our toxoid vaccine, we don't have to worry about antibiotic resistance. We directly target the alpha-haemolysin toxin," said Liangfang Zhang, a nanoengineering professor at UC San Diego Jacobs School of Engineering and the senior author on the paper. Targeting the alpha-haemolysin toxin directly has another perk. "These toxins create a toxic environment that serves as a defense mechanism which makes it harder for the immune system to fight Staph bacteria," explained Zhang.

Beyond MRSA and other staph infections, the nanosponge vaccine approach could be used to create vaccines that protect against a wide range of toxins, including those produced by E. coli and H. pylori.

This work from Zhang's Nanomaterials and Nanomedicine Laboratory at the UC San Diego included nanoengineering post-doctoral researcher Che-Ming "Jack" Hu, nanoengineering graduate student Ronnie Fang, and bioengineering graduate student Brian Luk.

The researchers found that their nanosponge vaccine was safe and more effective than toxoid vaccines made from heat-treated staph toxin. After one injection, just 10 percent of staph-infected mice treated with the heated version survived, compared to 50 percent for those who received the nanosponge vaccine. With two more booster shots, survival rates with the nanosponge vaccine were up to 100 percent, compared to 90 percent with the heat-treated toxin.

"The nanosponge vaccine was also able to completely prevent the toxin's damages in the skin, where MRSA infections frequently take place," said Zhang, who is also affiliated with the Moores Cancer Center at UC San Diego.

Fighting Pore-Forming Toxins

This work is a twist on a project the UC San Diego nanoengineers presented earlier this year: a nanosponge that can sop up a variety of pore-forming toxins—from bacterial proteins to snake venom—in the body.

Pore-forming toxins work by punching holes in a cell's membrane and letting the cell essentially leak to death. But when toxins attack the red blood cell membrane draped over the nanoparticle, "nothing will happen. It just locks the toxin there," Zhang explained.

The nanoengineers wondered what would happen if they loaded one of their nanosponges with staph toxin in this way, and presented the whole package to an essential part of the immune system called dendritic cells. Could the loaded particles trigger an immune response and work as a toxoid vaccine?

Staph toxin is so powerful that it kills immune cells in its unaltered form. Most vaccine candidates, therefore, use a heat or chemically processed version of the toxin that unravels some of its proteins and makes it a little weaker. But this process also makes the immune response to the toxin a little weaker.

"The more you heat it, the safer the toxin is, but the more you heat it, the more you damage the structure of the protein," Zhang explained. "And this structure is what the immune cell recognizes, and builds its antibodies against."

The nanosponge toxoid vaccine gets around this problem by detaining—but not changing—the staph toxin. Like a dangerous but handcuffed prisoner, the staph toxin can be led to the dendritic cells of the immune system without causing any harm.

Before this, "there was no way you could deliver a native toxin to the immune cells without damaging the cells," Zhang said. "But this technology allows us to do this."

Each vaccine particle is approximately 85 nanometers in diameter; for comparison, about 1000 of them would fit across the width of a single human hair. They are cleared from the body after injection in about two weeks, the researchers found.

Staphylococcus aureus

Staph bacteria are one of the most common causes of skin infections, and can cause blood poisoning and surgical infections as well as pneumonia. According to the Centers for Disease Control and Prevention, about 80,000 Americans suffer from invasive MRSA infections each year, and over 11,000 of those individuals die. At the moment, there are no vaccines approved to protect humans against the toxins associated with staph infections, including those caused by MRSA strains.

The idea for a staph vaccine came about when the researchers considered the success of their nanosponge. If the particle was so good at collecting toxins, they wondered, what were the potential uses of a particle full of toxin? "To be honest, we never thought about the vaccine use from the beginning," Zhang noted. "But when we do research, we always want to look at a problem in reverse."

In a way, the toxoid vaccine hearkens back to their first use for the particles, as a cancer drug delivery device, Zhang noted.

The particles "work so beautifully," Zhang said, that it might be possible to detain several toxins at once on them, creating "one vaccine against many types of pore-forming toxins," from staph to snake venom.



INFORMATION:



The research was funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (award no. R01DK095168) and by the National Science Foundation (grant DMR-1216461).

"Nanoparticle-detained toxins for safe and effective vaccination," by Che-Ming J. Hu, Ronnie H. Fang and Liangfang Zhang in the Department of NanoEngineering at the University of California, San Diego; and Brian T. Luk in the Department of Bioengineering at the University of California, San Diego.



ELSE PRESS RELEASES FROM THIS DATE:

The mystery of neutron stars heats up

2013-12-02
The mystery of neutron stars heats up Until now, scientists were pretty sure they knew how the surface of a neutron star – a super dense star that forms when a large star explodes and its core collapses into itself – can heat itself up. However, research by ...

Human stem cells converted to functional lung cells

2013-12-02
Human stem cells converted to functional lung cells Possibility of generating lung tissue for transplant using a patient's own cells NEW YORK, NY — For the first time, scientists have succeeded in transforming human stem cells into functional ...

Imaging shows long-term impact of blast-induced brain injuries in veterans

2013-12-02
Imaging shows long-term impact of blast-induced brain injuries in veterans CHICAGO – Using a special type of magnetic resonance imaging (MRI), researchers have found that soldiers who suffered mild traumatic brain injury (MTBI) induced by blast exposure ...

Cardiac MRI reveals energy drinks alter heart function

2013-12-02
Cardiac MRI reveals energy drinks alter heart function CHICAGO – Healthy adults who consumed energy drinks high in caffeine and taurine had significantly increased heart contraction rates one hour later, according to a study presented today at the ...

PRP therapy improves degenerative tendon disease in athletes

2013-12-02
PRP therapy improves degenerative tendon disease in athletes CHICAGO – Ultrasound-guided delivery of platelet-rich plasma (PRP) improves functionality and reduces recovery time in athletes with degenerative disease in their tendons, according to a study ...

MRI technique reveals low brain iron in ADHD patients

2013-12-02
MRI technique reveals low brain iron in ADHD patients CHICAGO – Magnetic resonance imaging (MRI) provides a noninvasive way to measure iron levels in the brains of people with attention deficit hyperactivity disorder (ADHD), according to a study being ...

Novel rehabilitation device improves motor skills after stroke

2013-12-02
Novel rehabilitation device improves motor skills after stroke CHICAGO – Using a novel stroke rehabilitation device that converts an individual's thoughts to electrical impulses to move upper extremities, stroke patients reported improvements in their ...

Special journal issue focuses on imaging screening

2013-12-02
Special journal issue focuses on imaging screening To be published online Monday, Dec. 2, a special issue of the Journal of the American College of Radiology addresses imaging-based screening and radiology's increasing role in preventive medicine. Topics covered ...

Messy children make better learners

2013-12-02
Messy children make better learners Study shows toddlers learn words for nonsolids better when getting messy in a highchair Attention, parents: The messier your child gets while playing with food in the high chair, the more he or she is learning. Researchers at ...

The Affordable Care Act: Translational research experiment to improve health

2013-12-02
The Affordable Care Act: Translational research experiment to improve health Science Translational Medicine editorial urges researchers to support the ACA BOSTON (December 2, 2013) – An editorial by Harry P. Selker, MD, MSPH, William ...

LAST 30 PRESS RELEASES:

Drones reveal extreme coral mortality after bleaching

New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia

Native habitats hold the key to the much-loved smashed avocado’s future

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

T cells take aim at Chikungunya virus

Gantangqing site in southwest China yields 300,000-year-old wooden tools

Forests can’t keep up: Adaptation will lag behind climate change

Sturgeon reintroduction initiative yields promising first-year survival rate

Study: Babies’ poor vision may help organize visual brain pathways

Research reveals Arctic region was permafrost-free when global temperatures were 4.5˚ C higher than today

Novel insights into chromophobe renal cell carcinoma biology and potential therapeutic strategies

A breakthrough in motor safety: AI-powered warning system enhances capability to uncover hidden winding faults

Research teases apart competing transcription organization models

Connect or reject: Extensive rewiring builds binocular vision in the brain

Benefits and risks: informal use of antibiotics to prevent sexually transmitted infections on the rise in key populations in the Netherlands

New molecular tool sheds light on how cancer cells repair telomeres

First large-scale stem cell bank enables worldwide studies on genetic risk for Alzheimer’s disease

[Press-News.org] 'Nanosponge vaccine' fights MRSA toxins